Trial Profile
Clinical study of ciclesonide(CIC) add-on to slmeterol/fluticasone propionate combination(SFC) and tiotropium in poorly controlled asthmatic patients with COPD.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Ciclesonide (Primary) ; Salmeterol/fluticasone propionate; Tiotropium bromide
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 19 Jan 2011 New trial record